| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 154948 | M-AMSA | 0.0490935610249067 | 0.46482142 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0490935610249067 | 0.28633391 |
| NSC 185065 | Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- | 0.0490935610249067 | 0.31697205 |
| NSC 18805 | .gamma.-Thujaplicine | 0.0490935610249067 | 0.38677421 |
| NSC 22709 | v-Triazolo[4,5-d]pyrimidin-7-ol | 0.0490935610249067 | 0.45079068 |
| NSC 275647 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- | 0.0490935610249067 | 0.61938545 |
| NSC 303861 | L-Cysteine analog | 0.0490935610249067 | 0.37644614 |
| NSC 33570 | Null | 0.0490935610249067 | 0.14997812 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0490935610249067 | 0.39447334 |
| NSC 359239 | Antibiotic X-14766A | 0.0490935610249067 | 0.19966071 |